ArticleThe Lancet. Rheumatology2021

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.

Jérôme Avouac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.